Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

BioTheryX
7966 Arjons Dr
San Diego, CA 92126
http://biotheryx.com/

BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition to develop treatments intended to extend and improve the quality-of-life of patients with life-threatening diseases. Our principal technology platform centers on targeted protein degradation, as well as PHM® 'molecular glues' that enable the design of small molecules to regulate protein equilibrium. This technology is designed to utilize the body's own protein disposal system to selectively degrade and remove disease-causing proteins. It has potential applicability to a broad range of diseases, including targets that have to date been considered 'undruggable'.

Key Contact
Name
David Stirling, Ph.D.
Title
CEO
Funding Events

Date
Amount
Type
Investors
07/28/20 $35,000,000 Series D MSD Partners